作者: V Manninen , L Tenkanen , P Koskinen , J K Huttunen , M Mänttäri
关键词: High-density lipoprotein 、 Medicine 、 Gemfibrozil 、 Internal medicine 、 Gastroenterology 、 Incidence (epidemiology) 、 Risk factor 、 Triglyceride 、 Relative risk 、 Placebo 、 Cholesterol 、 Endocrinology
摘要: BACKGROUND We studied the joint effect of baseline triglyceride and lipoprotein cholesterol levels on the incidence of cardiac end points in the trial group (n = 4,081) of the Helsinki …